Market Closed -
Australian S.E.
02:10:05 2024-04-29 am EDT
|
5-day change
|
1st Jan Change
|
0.021
AUD
|
-4.55%
|
|
0.00%
|
-6.67%
|
Fiscal Period: June |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
10.15
|
31.07
|
18.81
|
27.67
|
Enterprise Value (EV)
1 |
8.25
|
26.85
|
16.97
|
25.46
|
P/E ratio
|
-2.22
x
|
-5.62
x
|
-15.5
x
|
-205
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
11
x
|
22.6
x
|
2.62
x
|
1.8
x
|
EV / Revenue
|
8.98
x
|
19.5
x
|
2.36
x
|
1.65
x
|
EV / EBITDA
|
-4.47
x
|
-6.16
x
|
253
x
|
16.4
x
|
EV / FCF
|
-2,452,787
x
|
-4,688,784
x
|
-1,295,934
x
|
16,076,902
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
2.02
x
|
1.82
x
|
0.85
x
|
1.25
x
|
Nbr of stocks (in thousands)
|
507,591
|
862,981
|
1,106,731
|
1,106,731
|
Reference price
2 |
0.0200
|
0.0360
|
0.0170
|
0.0250
|
Announcement Date
|
8/27/20
|
8/31/21
|
9/22/22
|
8/31/23
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.0187
|
0.9191
|
1.375
|
7.18
|
15.39
|
EBITDA
1 |
-0.595
|
-1.847
|
-4.361
|
0.0672
|
1.551
|
EBIT
1 |
-0.5955
|
-1.869
|
-4.549
|
-0.6963
|
0.5077
|
Operating Margin
|
-3,177.23%
|
-203.36%
|
-330.8%
|
-9.7%
|
3.3%
|
Earnings before Tax (EBT)
1 |
-0.5977
|
-4.569
|
-5.089
|
-1.107
|
0.4914
|
Net income
1 |
-0.5977
|
-4.569
|
-4.336
|
-1.115
|
-0.0818
|
Net margin
|
-3,189%
|
-497.15%
|
-315.3%
|
-15.53%
|
-0.53%
|
EPS
2 |
-0.002079
|
-0.009002
|
-0.006410
|
-0.001099
|
-0.000122
|
Free Cash Flow
|
-
|
-3.363
|
-5.726
|
-13.09
|
1.583
|
FCF margin
|
-
|
-365.94%
|
-416.44%
|
-182.34%
|
10.29%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
102.09%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/27/20
|
8/27/20
|
8/31/21
|
9/22/22
|
8/31/23
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
0.95
|
1.9
|
4.22
|
1.85
|
2.21
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-3.36
|
-5.73
|
-13.1
|
1.58
|
ROE (net income / shareholders' equity)
|
-
|
-151%
|
-39.2%
|
-5.68%
|
2.21%
|
ROA (Net income/ Total Assets)
|
-
|
-35.2%
|
-23.7%
|
-1.99%
|
1.27%
|
Assets
1 |
-
|
12.99
|
18.28
|
56.16
|
-6.435
|
Book Value Per Share
2 |
0
|
0.0100
|
0.0200
|
0.0200
|
0.0200
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
Capex
1 |
0.03
|
1.45
|
3.44
|
2.92
|
3.11
|
Capex / Sales
|
160.06%
|
158.24%
|
250.34%
|
40.66%
|
20.18%
|
Announcement Date
|
8/27/20
|
8/27/20
|
8/31/21
|
9/22/22
|
8/31/23
|
|
1st Jan change
|
Capi.
|
---|
| -6.67% | 18.49M | | +31.96% | 272M | | +33.74% | 261M | | +49.42% | 194M | | +44.98% | 131M | | -28.57% | 121M | | +115.91% | 119M | | -42.17% | 119M | | 0.00% | 86.82M | | +150.00% | 75.33M |
Medical Farming
|